Neuroscience in Medical Technology
Navigation Links
Neuroscience in Medical Technology
Astrocytes Help Separate Man From Mouse
... story in the March 11 issue of the Journal of neuroscience . Scientists at the University of Rochester ... as neurons, had been pushed to the boundaries of neuroscience because of a gap in the tools used to study the ... is slow to change, and one of the dogmas of neuroscience is that astrocytes are support cells that don't ...... -- NeuroDiscovery Ltd (ASX: NDL), a specialty neuroscience service provider and drug development ... area of significant unmet medical need." neuroscience 2008, the Society for Neuroscience's 38th annual ... NeuroDiscovery Ltd is an ASX listed speciality neuroscience services provider and drug development company ...
... Specialty Pharmacy announced today that Teva neuroscience has selected Diplomat Specialty Pharmacy to be ... "We are honored that Teva neuroscience selected Diplomat to participate in this study," ... About Teva Neuroscience Teva neuroscience is the branded neurological products franchise ...
New Research Shows: Neurofeedback is an 'Evidence-Based' Treatment for ADHD
... this study - which will be published in the July issue of EEG and Clinical neuroscience - it could be concluded that Neurofeedback can indeed be considered an ... biofeedback in Epilepsy is published in the same issue of EEG and Clinical neuroscience demonstrating clinical efficacy in the treatment of epilepsy. ...Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
... said Henry A. Nasrallah, M.D., a clinical investigator who worked on the INVEGA(R) SUSTENNA(TM) clinical trials, and a Professor of Psychiatry and neuroscience and Director of the Schizophrenia Research Program at the University of Cincinnati College of Medicine. "The approval of once-monthly INVEGA(R) ...... MADISON, Wis., July 7 /PRNewswire/ -- In the midst of generally gloomy worldwide economic news and rising global tensions, an American neuroscience researcher has a message of hope: The answer for Alzheimer's disease and other degenerative diseases of the brain that cause memory loss may be much ...
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
... of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly-owned subsidiary, Alpharma, Inc., is also a leader in the development, registration, manufacturing and marketing of ...... of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly-owned subsidiary, Alpharma, Inc., is also a leader in the development, registration, manufacture and marketing of ...
... Florida's First Three-Year neuroscience Research Doctorate Program SARASOTA, Fla., June 18 /PRNewswire/ -- Sarasota's Roskamp Institute (Roskamp) today announced the first enrollment ...
... bank, as well as for samples obtained from the patients with autopsy-confirmed diagnoses. "Ultimately, the goal of the Blanchette Rockefeller neuroscience Institute (BRNI) is to cure Alzheimer's disease, and the path to a cure begins with detecting the disease early," said Senator Jay Rockefeller ...
Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
... safety and tolerability so that the symptoms can be stabilized and effectively treated," said Henry Nasrallah, M.D., professor of psychiatry and neuroscience and director of the schizophrenia research program at the University of Cincinnati College of Medicine. "Lurasidone has the potential to be an ...Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
... Business, a division of SK Holdings, is actively engaged in the innovative discovery and testing of novel therapeutic compounds in the field of neuroscience to treat epilepsy, depression, anxiety, schizophrenia, neuropathic pain and neurodegenerative disorders. The company has eight new drug candidates in ...... pain symptoms that affect day-to-day functioning and quality of life. About Arcion Arcion Therapeutics applies breakthroughs in neuroscience to advance the treatment of chronic pain. The company focuses on innovative topical treatments to provide pain relief with convenient application and ...
... Ophthalmology 2009 (ARVO 2009), This study, presented by Geoffrey P. Lewis, Ph.D. (along with G. Luna, J. Byun, E.A. Chapin and S.K. Fisher ) of the neuroscience Research Institute and Molecular Cell & Developmental Biology Department of the University of California, Santa Barbara , CA. has been accepted ...
Jubilant Enters Research Collaboration With AstraZeneca
... into the international pharmaceutical company's pre-clinical pipeline. Under the shared risk-reward collaboration, which will initially focus on the neuroscience area, Jubilant aims to deliver a steady stream of discovery programs to AstraZeneca. AstraZeneca will own the compounds developed under the ...Adding Steroid Drug to MS Treatment May Reduce Disease Activity
... The study was supported by Biogen Idec. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. For more information about AAN, visit ...Key Protein May Lead to Faster Acting Anti-Depression Drugs
... Research Center at The Rockefeller University , Dr. Jennifer L. Warner-Schmidt in New York and colleagues in Sweden, demonstrated in the Journal of neuroscience that the brain protein called p11 could lead pharmaceutical companies to develop anti-depression drugs that begin working within hours or days ...Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
... in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in neuroscience on June 29, 2007, in collaboration with researchers at University of California San Diego . Cautionary Statement Regarding Forward Looking ...For Iraq Veterans, Headaches Continue After Traumatic Brain Injury
... the Congressionally Directed Medical Research Program. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in ...Young Smokers Increase Risk for Multiple Sclerosis
... smoking is an environmental factor that can be avoided." The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in ...Can Exercising Your Brain Prevent Memory Loss?
... Relations Department for the password to this post. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in ...Neuralstem's ALS Trial on Clinical Hold
... in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in neuroscience on June 29, 2007, in collaboration with researchers at University of California San Diego . Cautionary Statement Regarding Forward Looking ...... that target neuronal nicotinic receptors (NNRs) with Targacept to treat cognitive disorders," said Bob Holland, Vice President and Head of the neuroscience Therapy Area, AstraZeneca. Targacept and AstraZeneca also announced that the lead compound arising out of the parties' preclinical research ...
Sosei Confirms the Safety of SD118 in Two Phase I Trials
... information about Sosei, please visit http://www.sosei.com About NeuroDiscovery NeuroDiscovery Ltd is an ASX listed speciality neuroscience services provider and drug development company which owns 100% of NeuroSolutions Ltd (ASX Code NDL). About NeuroSolutions ...Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
... in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in neuroscience on June 29, 2007, in collaboration with researchers at University of California San Diego. The Company expects to file its first IND (Investigational ...... to rapid weight loss and reduced food intake. The data was published online as of August 20, 2008 in the journal Synapse, a prestigious peer-reviewed neuroscience publication. Catalyst Pharmaceutical Partners is currently evaluating the use of CPP-109, its version of vigabatrin, for the treatment of both ...
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
... Company and Boehringer Ingelheim signed a long-term agreement to jointly develop and commercialize duloxetine hydrochloride. This partnership covers neuroscience indications in most countries outside of the United States and Japan, with few exceptions. About Eli Lilly and Company Lilly, a leading ...... affiliated hospitals. In addition, he was President of the Epilepsy Society of Southern New York. Dr. Tuchman is a frequent speaker about neuroscience topics at academic meetings. "There's a growing body of scientific and clinical evidence that supports the further development of drugs that block ...
Neuralstem Announces Issuance of Core Technology Patent in Europe
... in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in neuroscience on June 29, 2007, in collaboration with researchers at University of California San Diego. The company has also developed immortalized human neural ...How Big Is Your Brain? Its Size May Protect You from Memory Loss
... of Veterans Affairs and the National Institute on Aging. The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in ...Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
... -- Genaera Corporation (Nasdaq: GENR ) announced that preclinical data was presented Thursday at the Chicago Chapter of the Society of neuroscience by Mitchell F. Roitman, Ph.D., a Genaera collaborator and investigator with the University of Illinois at Chicago. The abstract titled "A ...UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
... of the Hospital Clinic at the University of Barcelona, Barcelona, Spain. He also serves as Director of Research at the Clinical Institute of neuroscience and he currently leads the Bipolar Research Program at the Spanish Research Network on Mental Disorders. According to Professor Montgomery, ...Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
... (DN). Data from the Phase 1b clinical trial were presented at the American Diabetes Association Meeting in June and the Society for neuroscience Meeting in November. The data demonstrate statistically significant improvement in quantitative sensory testing and clinically relevant ...The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
... to expedite the development of our technology platforms." "We are very excited to be establishing our drug discovery operations here. Pittsburgh's neuroscience research community is recognized for its leadership within the field, and this will allow us to staff our company with world-class neurobiologists," ...... company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include immunology and specific areas of oncology. Organon products are distributed in over ...
Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
... is KNS-760704, an orally bioavailable small molecule in development for the treatment of ALS. Knopp's leadership includes experienced neuroscience drug development and discovery executives formerly associated with major pharmaceutical companies. Knopp's financing has been led by Saturn Capital ...... a common molecular basis," explained Gene Robinson, PhD., senior author and G. William Arends Professor of Integrative Biology and Director of the neuroscience Program at the University of Illinois. "We used 454 Sequencing, together with the recently sequenced honey bee genome, to rapidly bring genomics to a ...
Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
... is KNS-760704, an orally bioavailable small molecule in development for the treatment of ALS. Knopp's leadership includes experienced neuroscience drug development and discovery executives formerly associated with major pharmaceutical companies. Knopp's financing has been led Saturn Capital Inc. ...... yet their results were similar to infants who were breastfed on average for 10 months." John Colombo, Ph.D., associate director for cognitive neuroscience and professor of psychology at the University of Kansas, said that the Birch study provides long-awaited data about the links between fatty acids in ...
Raptor Pharmaceuticals Provides Update of Product Programs
... blood-brain barrier ("BBB") transport models from its collaboration initiated in August 2006, Raptor has renewed its grant with Dr. William Mobley's neuroscience laboratory at Stanford University. In the first year of the collaboration, a number of RAP peptides were tested for their ability to cross the BBB. ...Other ContentslaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratoryventilationventilationventilationventilationventilationhighhighhighhighhighhighhighhighhighhighprogramprogramprogramprogramprogramprogramprogramprogramprogramtrainingtrainingtrainingtrainingtrainingtrainingtrainingtrainingscientistscientistscientistscientistscientistscientistwritingwritingwritingwritingwritingwritingOther TagsswimswimsignificantlysignificantlyCOXCOXheapheap
(Date:11/23/2009)...ngton, CT Current research suggests that a common... The related report by Nichols et al, "Unique Lip...Class of TLR2 Ligands Capable of Enhancing Autoimm... American Journal of Pathology . , Multiple scle...cks the brain and spinal cord, affects nearly 1 in...
(Date:11/23/2009)...S, Iowa - The only swine vaccine available for the...d infected with the virus. The vaccination marks t...d diagnosed with the pandemic flu., Iowa State U...ce, developed the vaccine this summer and has been...owa, Kansas and Illinois for several weeks., The...
(Date:11/23/2009)...ON, WI, November 16, 2009 -- A USDOE and USDA stud..., idle cropland, and cropland pasture could be con...nnial grasses, such as switchgrass, from which bio...tock. Economically viable production of a perennia...ies of biomass are removed annually is expected to...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 1REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 2REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 3REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 4REMERON 28R 29 Now Approved in Japan for the Treatment of Depression in Adult Patients 12964 5Finnish study identifies factors that increase death in stroke patients ages 15 to 49 51270 1Iontophoretic Drug Delivery System 28IDDS 29 Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intra 4705 1Iontophoretic Drug Delivery System 28IDDS 29 Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intra 4705 2(Date:11/24/2009)...dSANDIEGO,Nov.24/PRNewswire/--EnigmaDiagnosticsLim...nosticscompany,announcedtodayfourseniorappointment...illleadtheUSteamasPresidentandCEOwithGregHamilton,...StationedatEnigma,snewU.S.headquartersinSanDiego,C...ruitmentprogrammeplannedforassaydevelopment,R&...
(Date:11/24/2009)...RNewswire/--Theholidayseasoncanbeatimefullofjoy,ch...peciallythoserecoveringfromaneatingdisorder,it,sat...iluresandanxietyaboutanuncertainfuture.Familygathe...nbechallengingandsometimesawkward. ,, "Inmyprac...ereatingwiththefamily and duringtheholidayscanofte...
(Date:11/24/2009)....24/PRNewswire/--Quantros,aleadinghealthcareanalyt...nnouncedtodaythatithaslicensedintellectualproperty...higanforintegrationintoQuantros,suiteofsafetyandri...y,ssoftwarewithintheSRMproductfamilywillenableauto...hutilizationofahealthcareprovider,sintegratedadmin...
(Date:11/24/2009)...,Nov.24/PRNewswire-USNewswire/--IPROhasachievedits...alitymanagementstandardfocusedonfulfillingcustomer...nuallyimprovingbusinessperformance.Certificationto...smeansIPRO,sQualityManagementSystem(QMS)haspasseda...ficesinLakeSuccessandAlbany,NewYorkaswellasatitsaf...
(Date:11/24/2009)...ng sedatives, antidepressants, benzodiazepines, re...ay News) -- Seniors who take antidepressants, seda... increased risk for falls, a new review shows. ,...es that included a total of 79,081 participants ol... drugs: high blood pressure medicines; diuretics; ...
Breaking Medicine News(10 mins):Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 2Health News:Enigma Diagnostics Expands Its US and European Executive Management Teams 3Health News:When Holiday Meals Aren't a Gift 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2[0] Enigma Diagnostics Expands Its US and European Executive Management Teams[0] When Holiday Meals Aren't a Gift[0] Quantros Licenses Adverse Event Identification Technology from University of Michigan[0] IPRO Earns Third Consecutive Quality Management Certification[0] Some Prescription Meds May Raise Seniors' Risks of Falling
endorphinsmirthfulexpectationswimMinnnovofacilitatesdefinedthwartingmodeledsignificantlyCOXbonefishheap
Other Tagschemical 2chemical 3chemical 4chemical 5chemical 6chemical 7chemical 8chemical 9chemical 10foetus 2transcription 2transcription 3transcription 4transcription 5transcription 6transcription 7prediction 2prediction 3enables 2enables 3enables 4enables 5enables 6enables 7enables 8enables 9enables 10modification 2modification 3modification 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |